Tomosynthesis Market - By Type (2D Tomosynthesis, 3D Tomosynthesis), By Application (Breast Cancer Screening, Chest Imaging, Evaluation of Erosions in Rheumatoid Arthritis, Head and Neck Imaging, etc.), By Segmentation (Regulatory Framework, Technological Insights, etc), By Market Analysis (Introduction, Segment Overview, Hospitals, Diagnostic Centers, etc.), By Geography - Global Opportunity Analysis & Industry Forecast, 2022-2030

Report Code: HCR 1514 Report Format: PDF + Excel

Tomosynthesis Market Overview:

The Tomosynthesis market can be segmented based on end-users and regions. It is projected to achieve a significant market size of $3500 billion by 2030, with a compound annual growth rate (CAGR) of 14% during the forecast period of 2023-2030.

The adoption of this market, also known as 3D mammography, is on the rise in the medical imaging field. It offers numerous benefits compared to traditional 2D mammography, including enhanced cancer detection rates and improved visualization of breast abnormalities. The growth is primarily fueled by factors such as the increasing incidence of breast cancer, technological advancements, and the demand for more precise diagnostic tools.

Regulatory approvals in multiple countries have facilitated the integration of Tomosynthesis into healthcare facilities and imaging centers. However, there are some challenges associated with this technology, such as high equipment costs, limited availability in certain regions, and the necessity for specialized training for radiologists.

For the most up-to-date and comprehensive market information, it is recommended to consult industry reports, market research studies, and the latest news developments in this field.

Market Snapshot:  

Tomosynthesis Market- Report Coverage:
The “Tomosynthesis Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Biochar Market.


By Type

  • 2D Tomosynthesis

  •  3D Tomosynthesis

By Application

  • Breast Cancer Screening

  • Chest Imaging

  • Evaluation of Erosions in Rheumatoid Arthritis

  • Head and Neck Imaging

  •  Others

By Segmentation

  • Regulatory Framework

  • Technological Insights 

By Market Analysis

  • Introduction

  • Segment Overview

  • Hospitals

  • Diagnostic Centers

By Geography 

  • North America (U.S., Canada and Mexico)

  • Europe (Germany, France, UK, Italy, Spain, Russia and the Rest of Europe),

  • Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and the Rest of Asia-Pacific),

  • South America (Brazil, Argentina, Chile, Colombia and the Rest of South America)

  • Rest of the World (Middle East and Africa).

Tomosynthesis Market - Top Trends:

Increasing Adoption: The use of 3D mammography, also known as Tomosynthesis, has been on the rise, with healthcare providers worldwide increasingly incorporating this advanced technology. It offers improved accuracy in cancer detection compared to traditional 2D mammography, leading to earlier diagnosis and better patient outcomes.

Growing Focus on Breast Cancer Screening: Cancer remains a significant global health concern, and early detection is crucial for successful treatment. Tomosynthesis has emerged as an important tool for cancer screening due to its ability to provide detailed 3D images of tissue, reducing false-positive and false-negative results.

Technological Advancements: The market has witnessed continuous technological advancements to enhance image quality, reduce radiation exposure, and improve the overall patient experience.

Integration with Other Imaging Modalities: Integration of with other imaging modalities, such as ultrasound and magnetic resonance imaging (MRI), is gaining traction. This integration enables a more comprehensive evaluation of breast abnormalities and assists in guiding biopsy procedures.

Tomosynthesis Market - Company Analysis

The market is a rapidly growing sector within the medical industry, also known as 3D mammography, is an advanced technique that allows for the creation of three-dimensional images of the breast using X-ray technology. It offers improved accuracy in detecting breast cancer compared to traditional mammography, especially in dense breast tissue.
When analyzing the companies in the market, several key players stand out. Here are some prominent companies involved in the development and manufacturing of the system
Hologic, Inc.: is a leading company, known for its innovative 3D mammography systems. Their flagship product, the Hologic Selenia Dimensions system, is widely used in breast cancer screening and diagnosis.

GE Healthcare: GE Healthcare is a major player in the medical field, including. Their Sinclair system combines digital mammography with enhanced capabilities for breast cancer detection.

Siemens Healthineers: this company offers Tomosynthesis solutions as part of its comprehensive mammography portfolio. Their systems, such as the MAMMOMAT Revelation, provide advanced options for breast cancer screening.

Fujifilm Holdings Corporation: Fujifilm has a strong presence in with its Amulet Inn ovality system. The company's offering focuses on improving the accuracy of breast cancer diagnosis through advanced imaging technologies.

Planmed Oy: this company specializes in breast imaging equipment, including Tomosynthesis systems. Their Planned Clarity 3D system is designed to provide high-quality images for efficient breast cancer screening.  

Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies players in the Tomosynthesis Market adopt. The top 10 companies in Tomosynthesis Market are listed below:
  1. Hologic, Inc
  2. GE Healthcare
  3. Siemens Healthineers
  4. Fujifilm Holdings Corporation
  5. Planmed Oy
  6. Dexela ltd
  7. PerkinElmer
  8. Trivitron Healthacre
  9. iCAD
  10. Toshiba Medical Systems

Scope of Report: 

Report MetricDetails

Base Year Considered


Forecast Period




Market Size in 2030


Segments Covered

Regulatory Framework, Technological Insights

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Key Market Players

  1. Hologic, Inc

  2. GE Healthcare

  3. Siemens Healthineers

  4. Fujifilm Holdings Corporation

  5. Planmed Oy

  6. Dexela ltd

  7. PerkinElmer

  8. Trivitron Healthacre

  9. iCAD

  10. Toshiba Medical Systems

For more Lifesciences and Healthcare Market reports, please Click Here
1. Tomosynthesis Market  Overview
    1.1 Definitions and Scope
2. Tomosynthesis Market– Executive Summary
3. Tomosynthesis Market– Market Landscape
    3.1 Company Benchmarking – Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis – Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Tomosynthesis Market– Startup Company Scenario 
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Tomosynthesis Market– Market Entry Scenario Premium 
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Tomosynthesis Market– Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porter’s Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes
7. Tomosynthesis Market– Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Tomosynthesis Market– By Type (Market Size - $Million/$Billion)                                  
    8.1 2D Tomosynthesis
        8.1.1 Market Trends by Region 
        8.1.2 Market Share & Forecast by Region
    8.2 3D Tomosynthesis
        8.2.1 Market Trends by Region 
        8.2.2 Market Share & Forecast by Region
    8.3 Others 
9. Tomosynthesis Market – By Application (Market Size - $Million/$Billion)
    9.1 Breast Cancer Screening
        9.1.1 Market Trends by Region
        9.1.2 Market Share & Forecast by Region
    9.2 Chest Imaging
        9.2.1 Market Trends by Region
        9.2.2 Market Share & Forecast by Region
    9.3 Evaluation of Erosions in Rheumatoid Arthritis
        9.3.1 Market Trends by Region
        9.3.2 Market Share & Forecast by Region
    9.4 Head and Neck Imaging
        9.4.1 Market Trends by Region
        9.4.2 Market Share & Forecast by Region
    9.5 Others
        9.5.1 Market Trends by Region
        9.5.2 Market Share & Forecast by Region
10. Tomosynthesis Market Segmentation & Impact Analysis
    10.1 Regulatory Framework
        10.1.1 Market Trends by Region
        10.1.2 Market Share & Forecast by Region
    10.2 Technological Insights
        10.2.1 Market Trends by Region
        10.2.2 Market Share & Forecast by Region
11. Tomosynthesis Market– By Market Analysis (Market Size - $Million/$Billion)
    11.1 Introduction
    11.2 Segment Overview 
        11.2.1 Market Trends by Region
        11.2.2 Market Share & Forecast by Region
    11.3 Hospitals
        11.3.1 Market Trends by Region
        11.3.2 Market Share & Forecast by Region
    11.4 Diagnostic Centers
        11.4.1 Market Trends by Region
        11.4.2 Market Share & Forecast by Region
12. Tomosynthesis Market– by Geography (Market Size - $Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 Germany
        12.2.2 France
        12.2.3 U.K.
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 Japan
        12.3.3 South Korea
        12.3.4 India
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia-Pacific
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Chile
        12.4.4 Colombia
        12.4.5 Rest of South America
    12.5 Rest of the World
        12.5.1 Middle East
        12.5.2 Africa
13. Tomosynthesis Market– Market Entropy
    13.1 New product launches
    13.2 M&A’s, collaborations, JVs and partnerships
14. Tomosynthesis Market– Industry Competition Landscape 
    14.1 Market Share Analysis
        14.1.1 Market Share by Technology – Key Companies
        14.1.2 Market Share by Country – Key Companies
        14.1.3 Market Share by Region – Key Companies
    14.2 Competition Matrix
    14.3 Best Practices for Companies
15. Tomosynthesis Market– Key Company List by Country Premium 
16. Tomosynthesis Market– Company Analysis
    16.1 Hologic Inc
    16.2 GE Healthcare
    16.3 Siemens Healthineers
    16.4 Fujifilm Holdings Corporation
    16.5 Planmed Oy
    16.6 Dexela ltd
    16.7 PerkinElmer
    16.8 Trivitron Healthacre
    16.9 iCAD
    16.10 Toshiba Medical Systems
    16.11 General Electric Company
    16.12 Inc
    16.13 Koninklijke Philips N.V
    16.14 Fujifilm Medical Systems U.S.A Inc
    16.15 Agfa-Gevaert Group
    16.16 Analogic Corporation
    16.17 Shimadzu
    16.18 Planmeca
"Financials would be provided to private companies on best-efforts basis." 
Connect with our experts to get customized reports that best suit your requirements. Our reports include global-level data, niche markets and competitive landscape.

The Tomosynthesis Market is projected to grow at 14% CAGR during the forecast period 2023-2030.

Tomosynthesis Market size is estimated to reach 3500 billion by 2030

The Top Companies in the Tomosynthesis Market are Hologic, Inc, GE Healthcare, Siemens Healthineers, Fujifilm Holdings Corporation, Planmed, Dexela ltd, PerkinElmer, Trivitron Healthacre, iCAD, Toshiba Medical Systems